The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Oncology; Bristol-Myers Squibb; Eisai; Ipsen; Pfizer; Sanofi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ipsen; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Exelis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
Hyperprogressive disease in patients with metastatic genitourinary tumors treated with immune checkpoint inhibitors.
 
Cristina Suárez
No Relationships to Disclose
 
Rafael Morales-Barrera
Consulting or Advisory Role - MSD, Sanofi, Astra Zeneca
Speakers' Bureau - Asofarma; MSD Oncology
Travel, Accommodations, Expenses - MSD, Sanofi, Astra Zeneca, Astellas, J&J, Bayer
 
Alonso Garcia-Ruiz
No Relationships to Disclose
 
Macarena Gonzalez
Travel, Accommodations, Expenses - Astellas Medivation; Bayer; Roche
 
Marta Ligero
No Relationships to Disclose
 
Claudia Valverde
Consulting or Advisory Role - Eisai; Lilly; Novartis; Takeda
Speakers' Bureau - Lilly
Research Funding - Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - Bayer; Lilly; Novartis; Pfizer; PharmaMar
 
Cesar Serrano
Consulting or Advisory Role - Deciphera
Research Funding - Bayer; Deciphera; Pfizer
 
Joaquin Mateo
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Astellas Pharma; AstraZeneca; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Sanofi
 
Raquel Perez-Lopez
No Relationships to Disclose
 
Joan Carles
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Johnson & Johnson; MSD Oncology; Pfizer; Sanofi
Speakers' Bureau - Asofarma; Bayer; Johnson & Johnson